Frontlight ResearchEarly access
Psoriatic arthritis trials in China
5 of 12 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationMass Spectrometry-based Immune Profiling in Autoimmune Diseases
- Where
- Beijing
- Age
- 18 years and over
- People
- 500
- Run by
- Peking University People's Hospital
See details and how to joinNCT07188285 - No phaseEnrolling by invitationA Real-World Study of Biologic Therapy for Subclinical Psoriatic Arthritis
- Where
- Fuzhou
- Age
- 18 years and over
- People
- 150
- Run by
- Chao Ji
See details and how to joinNCT06686082 - No phaseNot yet taking people in ChinaReal-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)
- Where
- Hunan
- Age
- 18 years and over
- People
- 1,000
- Run by
- Chongqing Genrix Biopharmaceutical Co., Ltd
See details and how to joinNCT06802848 - No phaseNot yet taking people in ChinaA Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.
- Where
- Hangzhou
- Age
- 18 years and over
- People
- 10,000
- Run by
- Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06766552 - No phaseTaking peopleProspective Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)
- Where
- Nanjing
- Age
- 18 years and over
- People
- 400
- Run by
- Nanjing Medical University
See details and how to joinNCT06730334